Lynn Butler
Geen lopende functies
Profiel
Lynn Butler was the Chief Executive Officer at Sirenade Pharmaceuticals AG.
Eerdere bekende functies van Lynn Butler
Bedrijven | Functie | Einde |
---|---|---|
Sirenade Pharmaceuticals AG
Sirenade Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services SIRENADE Pharmaceuticals AG provides preclinical research and development services. Core clinical and preclinical competencies are an articulated pipeline of projects in CNS and oncology. The firm focuses projects that target Alzheimer's disease, Parkinson disease and migraine. Out of three preclinical projects, one targets Alzheimer's disease and two early stage projects are targeting solid tumors and other cancers with unmet medical need. The company uses a proprietary integrated research and development platform that addresses nucleotide-binding targets and kinases. The company was founded in 2004 and is headquartered in Munich, Germany. | President | 25-07-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Sirenade Pharmaceuticals AG
Sirenade Pharmaceuticals AG Miscellaneous Commercial ServicesCommercial Services SIRENADE Pharmaceuticals AG provides preclinical research and development services. Core clinical and preclinical competencies are an articulated pipeline of projects in CNS and oncology. The firm focuses projects that target Alzheimer's disease, Parkinson disease and migraine. Out of three preclinical projects, one targets Alzheimer's disease and two early stage projects are targeting solid tumors and other cancers with unmet medical need. The company uses a proprietary integrated research and development platform that addresses nucleotide-binding targets and kinases. The company was founded in 2004 and is headquartered in Munich, Germany. | Commercial Services |